592 related articles for article (PubMed ID: 6694097)
1. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
Marek GJ; Seiden LS
J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
[TBL] [Abstract][Full Text] [Related]
3. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
4. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
Cohen ML; Colbert WE
J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
Eison AS; Yocca FD; Gianutsos G
J Pharmacol Exp Ther; 1988 Aug; 246(2):571-7. PubMed ID: 2900327
[TBL] [Abstract][Full Text] [Related]
6. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
7. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
8. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
[TBL] [Abstract][Full Text] [Related]
9. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
Marek GJ; Li AA; Seiden LS
J Pharmacol Exp Ther; 1989 Jul; 250(1):52-9. PubMed ID: 2746510
[TBL] [Abstract][Full Text] [Related]
10. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
Brady LS; Barrett JE
J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546
[TBL] [Abstract][Full Text] [Related]
11. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
12. Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation.
Bond RA; Ornstein AG; Clarke DE
J Pharmacol Exp Ther; 1989 May; 249(2):401-10. PubMed ID: 2724131
[TBL] [Abstract][Full Text] [Related]
13. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
14. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
15. [The role of serotonin in the behavioral changes induced in the rat by cyclazocine].
Gavend MR; Serre-Debeauvais F; Gavend M
J Pharmacol; 1986; 17(4):601-14. PubMed ID: 3560971
[TBL] [Abstract][Full Text] [Related]
16. Specificity of a rat behavioral model for serotonin receptor activation.
Sloviter RS; Drust EG; Connor JD
J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
[TBL] [Abstract][Full Text] [Related]
17. Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.
Cohen ML; Schenck KW; Colbert W; Wittenauer L
J Pharmacol Exp Ther; 1985 Mar; 232(3):770-4. PubMed ID: 3973826
[TBL] [Abstract][Full Text] [Related]
18. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
Ganey PE; Sprugel KH; Hadley KB; Roth RA
J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
Yoshioka M; Goda Y; Togashi H; Matsumoto M; Saito H
J Pharmacol Exp Ther; 1992 Feb; 260(2):917-24. PubMed ID: 1531363
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
Yap CY; Taylor DA
Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
